Compare Elixinol Global (ELLXF) With Other Cannabis Stocks

Head-to-head stock comparisons across price, valuation, financials, and growth metrics

Company

Elixinol Global (ELLXF)

Price

$0.01

Change

0.00%

Market Cap

$1.9M

Sector

CBD

CBD Sector Peers

All CBD cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.

TickerNamePriceChange %MCap
CWBHFCharlotte's Web Holdings$0.62-0.22%$99.3M
PKANFSimply Better Brands$0.210.00%$22.2M
YCBDcbdMD Inc$0.71-0.75%$7.5M
PCLOFPharmaCielo$0.04-26.40%$7.4M
OILFFNextleaf Solutions$0.04+1.93%$7.1M
CVSICV Sciences$0.04-12.42%$6.5M
DHBUFDelivra Health Brands$0.14+10.51%$4.4M
CBDNFCBD Global Sciences$0.04+16.39%$1.8M
GBHPFGlobal Hemp Group$0.010.00%$178.0K
CNTRFCentr Brands$0.010.00%$139.2K

Top Matchups by Market Cap

Companies closest to Elixinol Global in market capitalization — the most meaningful head-to-head comparisons.

AYRWFMSO

Ayr Wellness

MCap: $1.9M

$0.02-8.57%
Compare
CBDNFCBD

CBD Global Sciences

MCap: $1.8M

$0.04+16.39%
Compare
XXIIBiotech

22nd Century Group

MCap: $2.0M

$3.88+1.97%
Compare
AKANInternational

Akanda Corp

MCap: $1.7M

$0.82-2.84%
Compare
CANBMSO

Canbiola Inc

MCap: $1.4M

$0.020.00%
Compare

Cross-Sector Comparisons

Top cannabis companies outside the CBD sector. Compare across different business models and market segments.

JAZZBiotech

Jazz Pharmaceuticals

MCap: $10.99B

$178.55-1.66%
Compare
SMGAncillary

Scotts Miracle-Gro

MCap: $3.54B

$60.96+0.96%
Compare
CURLFMSO

Curaleaf Holdings

MCap: $1.80B

$2.36+2.83%
Compare
TPBAncillary

Turning Point Brands

MCap: $1.73B

$90.62+0.69%
Compare
GTBIFMSO

Green Thumb Industries

MCap: $1.54B

$6.56+7.01%
Compare

Comparing ELLXF in the Cannabis Market

Elixinol Global (ELLXF) is a CBD-sector cannabis company trading at $0.01 per share with a market capitalization of $1.9M. Among its CBD peers, ELLXF ranks #8 by market cap, with trailing twelve-month revenue of $0 and a gross margin of 0.0%. The stock has moved 0.00% in the current session, trading on the OTC exchange.

When comparing ELLXF against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio (N/A), revenue growth (0.00% YoY), and balance sheet strength (cash of $0 vs. debt of $0). The comparison tables above allow you to evaluate Elixinol Global relative to 10 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.

Frequently Asked Questions

How does ELLXF compare to other CBD stocks?+
Elixinol Global has a market cap of $1.9M, placing it among 11 companies in the CBD sector. Its price-to-sales ratio is N/A and its gross margin is 0.0%. Use the table above to compare these metrics against every CBD peer.
What is ELLXF's biggest competitor?+
By market capitalization, the closest comparable company is Ayr Wellness (AYRWF) with a market cap of $1.9M. Click the compare link to view a full head-to-head analysis.
Is ELLXF overvalued compared to its peers?+
Elixinol Global trades at a P/S ratio of N/A. Compare this to sector peers in the table above to determine relative valuation. A lower P/S may indicate relative value, while a higher P/S may reflect growth expectations.
Which cannabis stock has better margins than ELLXF?+
Elixinol Global has a gross margin of 0.0%. Among its CBD peers, 1 companies report higher gross margins. See the Sector Peers table for a full ranking.
Can I compare ELLXF to stocks in other cannabis sectors?+
Yes. The Cross-Sector Comparisons section above features top companies from sectors outside CBD. You can click any company to see a full side-by-side comparison with ELLXF covering price, valuation, financials, and growth metrics.

Related Pages

Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.